State Street Corp Dynavax Technologies Corp Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Dynavax Technologies Corp stock. As of the latest transaction made, State Street Corp holds 7,690,274 shares of DVAX stock, worth $100 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,690,274
Previous 7,962,775 3.42%
Holding current value
$100 Million
Previous $89.4 Million 4.2%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$10.05 - $11.61 $2.74 Million - $3.16 Million
-272,501 Reduced 3.42%
7,690,274 $85.7 Million
Q2 2024

Aug 14, 2024
SELL
$10.73 - $12.58 $28.4 Million - $33.3 Million
-2,648,966 Reduced 24.96%
7,962,775 $89.4 Million
Q1 2024

May 15, 2024
BUY
$11.7 - $14.98 $13.1 Million - $16.7 Million
1,115,956 Added 11.75%
10,611,741 $132 Million
Q4 2023

Feb 14, 2024
BUY
$13.09 - $14.98 $16.2 Million - $18.6 Million
1,239,597 Added 15.01%
9,495,785 $133 Million
Q3 2023

Nov 14, 2023
BUY
$12.64 - $14.99 $5.91 Million - $7.01 Million
467,821 Added 6.01%
8,256,188 $122 Million
Q2 2023

Aug 14, 2023
SELL
$9.85 - $13.17 $11.4 Million - $15.2 Million
-1,155,281 Reduced 12.92%
7,788,367 $101 Million
Q1 2023

May 15, 2023
SELL
$9.44 - $11.88 $9.9 Million - $12.5 Million
-1,048,856 Reduced 10.5%
8,943,648 $87.7 Million
Q4 2022

Feb 14, 2023
SELL
$10.27 - $13.29 $2.89 Million - $3.74 Million
-281,726 Reduced 2.74%
9,992,504 $106 Million
Q3 2022

Nov 15, 2022
BUY
$9.93 - $17.44 $16.3 Million - $28.7 Million
1,644,803 Added 19.06%
10,274,230 $107 Million
Q2 2022

Aug 15, 2022
BUY
$7.45 - $12.83 $973,677 - $1.68 Million
130,695 Added 1.54%
8,629,427 $109 Million
Q1 2022

May 16, 2022
BUY
$9.75 - $14.44 $22 Million - $32.5 Million
2,253,376 Added 36.08%
8,498,732 $92.1 Million
Q4 2021

Feb 14, 2022
BUY
$13.17 - $20.94 $13.6 Million - $21.6 Million
1,031,099 Added 19.77%
6,245,356 $87.9 Million
Q3 2021

Nov 15, 2021
SELL
$9.16 - $19.83 $16.5 Million - $35.6 Million
-1,796,822 Reduced 25.63%
5,214,257 $100 Million
Q2 2021

Aug 16, 2021
SELL
$7.25 - $10.99 $526,966 - $798,808
-72,685 Reduced 1.03%
7,011,079 $69.1 Million
Q1 2021

May 17, 2021
SELL
$4.57 - $11.18 $17.4 Million - $42.5 Million
-3,803,532 Reduced 34.94%
7,083,764 $69.6 Million
Q4 2020

Feb 16, 2021
SELL
$3.73 - $5.6 $2.67 Million - $4.01 Million
-715,811 Reduced 6.17%
10,887,296 $48.4 Million
Q3 2020

Nov 10, 2020
BUY
$4.32 - $11.7 $28.3 Million - $76.6 Million
6,544,323 Added 129.37%
11,603,107 $50.1 Million
Q2 2020

Aug 14, 2020
BUY
$2.94 - $9.1 $4.82 Million - $14.9 Million
1,640,072 Added 47.97%
5,058,784 $44.9 Million
Q1 2020

May 11, 2020
BUY
$2.27 - $6.2 $7.76 Million - $21.2 Million
3,418,712 New
3,418,712 $12.1 Million

Others Institutions Holding DVAX

# of Institutions
275
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.64B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email